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randomised non-inferiority trial
Kim Mathiasen1,2*, Tonny E. Andersen1, Heleen Riper3, Annet A. M. Kleiboer3 and Kirsten K. Roessler1
Abstract
Background: Internet based cognitive behavioural therapy (iCBT) has been demonstrated to be cost- and clinically
effective. There is a need, however, for increased therapist contact for some patient groups. Combining iCBT with
traditional face-to-face (ftf) consultations in a blended format (B-CBT) may produce a new treatment format with
multiple benefits from both traditional CBT and iCBT such as individual adaptation, lower costs than traditional
therapy, wide geographical and temporal availability, and possibly lower threshold to implementation. The primary
aim of the present study is to compare directly the clinical effectiveness of B-CBT with face-to-face CBT for adult
major depressive disorder.
Methods/Design: The study is designed as a two arm randomised controlled non-inferiority trial comparing
blended CBT for adult depression with treatment as usual (TAU). In the blended condition six sessions of ftf CBT is
alternated with six to eight online modules (NoDep). TAU is defined as 12 sessions of ftf CBT. The primary outcome
is symptomatic change of depressive symptoms on the patient-health questionnaire (PHQ-9). Additionally, the
study will include an economic evaluation. All participants must be 18 years of age or older and meet the
diagnostic criteria for major depressive disorder according to the Diagnostic and Statistical Manual of Mental
disorders 4th edition. Participants are randomised on an individual level by a researcher not involved in the project.
The primary outcome is analysed by regressing the three-month follow-up PHQ-9 data on the baseline PHQ-9 score
and a treatment group indicator using ancova. A sample size of 130 in two balanced groups will yield a power of
at least 80% to detect standardised mean differences above 0.5 on a normally distributed variable.
Discussion: This study design will compare B-CBT and ftf CBT in a concise and direct manner with only a
minimal of the variance explained by differences in therapeutic content. On the other hand, while situated in
routine care, ecological validity is somewhat compromised by the controlled manner in which the study is
conducted.
Trial registration: ClinicalTrials.gov NCT02796573. Registered June 1st 2016. Currently recruiting participants.
Background
Depression is a prevalent and disabling disorder with a
high risk of relapse and large individual and societal costs
[1–6]. Effective treatments exist [7], but there is a large
gap between the need for and use of treatments [8]. Evi-
dence based psychotherapies such as CBT, may help to
bridge this gap. The reach of face-to-face (ftf) CBT is lim-
ited [9] however, which has led researchers to explore
alternative modes of delivery of CBT such as Internet
based guided self-help (iCBT) [10–16]. In spite of the evi-
dence for the effect of iCBT, there is a need for increased
therapist contact among some patient groups to overcome
some of the shortcomings of iCBT [17–20].
Combining iCBT with traditional face-to-face consul-
tations in a blended CBT format (B-CBT) may alleviate
some of the difficulties associated with iCBT (such as
lack of clinician contact), while still preserving some of
the advantages of iCBT and face-to-face CBT alike. In B-
CBT, online modules and face-to-face consultations are
combined in one coherent treatment manual. This for-
mat could hold multiple benefits. Firstly, by providing
face-to-face sessions, the therapist can individualise the
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therapy by taking the personal profile of the patient, the
disorder, and possible co-morbidity into account. Sec-
ondly, since B-CBT only provides half the number of
sessions as traditional face-to-face CBT, the capacity of
the treating clinician is increased compared to trad-
itional CBT. Third, the burden and cost of travel by the
patient can be reduced. Fourth, the online modules are
available at the time and place needed by the patients -
and they can be re-viewed multiple times. Fifth, the in-
herently structured format of the online modules secures
the same level of psycho-education and exercises to be
delivered to all patients. Finally, one of the principal bar-
riers for the uptake of iCBT seems to be skepticism from
clinicians towards leaving the majority of therapy to a
computer [21], a barrier possibly alleviated by the
blended format in B-CBT.
Few studies have investigated the use of blended care
combining internet based psychotherapeutic modules and
face-to-face sessions into one coherent treatment manual
[22–26]. Generally, however, they do indicate positive out-
comes. In a randomised controlled trial conducted in pri-
mary care in Tromsø, Norway clinical psychologists
delivered 30 min sessions following each online module
[24]. They were able to document a significant difference
with a moderate to large effect size (d = 0.65) on depres-
sive symptoms (BDI-II) favouring blended care over wait-
ing list. The intervention predominantly received positive
evaluations suggesting acceptability and satisfaction with
the treatment. Additionally, a qualitative study found that
the face-to-face consultations increased motivation to per-
sist with the iCBT programme [27]. Another recent ex-
ample is the development and initial evaluation of a
programme for B-CBT in The Netherlands. This was
tested in an outpatient clinic of a specialised mental health
care centre in Amsterdam. The study was designed as a
feasibility study and included only nine patients. However,
the patients perceived the intervention as positive al-
though the authors rightly note that no conclusion can be
derived from such a small sample [26].
Aims and hypotheses
The primary aim of the present study is to compare the
clinical effectiveness of blended cognitive behavioural
therapy (B-CBT) for major depressive disorder (MDD)
in adults with treatment as usual (TAU) defined as 12
sessions of face-to-face CBT. It is hypothesised that B-
CBT will be no less clinically effective than TAU, and
that it will be acceptable and satisfactory to patients and
clinicians.
Methods
Design
The study is designed as a two arm randomised con-
trolled non-inferiority trial comparing B-CBT for adult
depression to treatment as usual (TAU) with an eco-
nomic evaluation alongside. The present trial is part of
the national project ENTER located and coordinated
from the Center for Telepsychiatry and is additionally
affiliated with the EU-study E-COMPARED [28].
Participants
Inclusion criteria
All participants must be 18 years of age or older and
meet the diagnostic criteria for major depressive dis-
order according to the Diagnostic and Statistical Manual
of Mental disorders 4th edition (DSM-IV) [29]. Add-
itionally, the participants must score ‘5’ or higher on the
Patient Health Questionnaire-9 (PHQ-9) [30].
Exclusion criteria
Patients will be excluded in case of current high risk of
suicide or if they suffer from a co-morbid substance de-
pendence, bipolar affective disorder, psychotic illness, or
obsessive compulsive disorder. Additionally, participants
will be excluded if they currently receive psychological
treatment for depression in primary or specialised men-
tal health care. Finally, they will be excluded if they are
unable to comprehend Danish or if they do not have ac-
cess to a PC and Internet connection.
Recruitment
Participants are recruited from the Centre for Telepsy-
chiatry in specialised mental health care at the Mental
Health Services of the Region of Southern Denmark,
where they are referred to the study by clinicians. Ini-
tially, however, patients are self-referred to the Centre
for Telepsychiatry.
The diagnosis will be confirmed by telephone adminis-
tered interviews using the International Neuropsychiatric
Interview version 5.0 (M.I.N.I.) [31] administered via tele-
phone by trained masters students in psychology. Add-
itionally, the participants are asked for permission from
the research team to obtain the results of the PHQ-9
questionnaire from their application form to minimise the
burden on the patients. Patients are asked to keep even-
tual antidepressant medication stable during treatment. If
changes should occur, they are asked to report it.
Randomisation and blinding
An independent researcher who is not involved in the
trial performs the randomisation (centrally from
Amsterdam) at an individual level, stratified by country
after eligibility and baseline measurement. A compu-
terised random number generator (Random Allocation
Software) will be applied with an allocation ratio of 1:1.
Block randomisation will be used with variable block
sizes that vary between eight and fourteen allocations
per block.
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The assessors for eligibility will be blinded to group al-
location. During treatment, blinding of participants and
clinicians are naturally impossible. Researchers and stat-
isticians involved in the analyses will be blinded to group
allocations. The groups will be numbered in the dataset
without revealing which treatment was given. The ques-
tionnaires administered solely to the B-CBT group will
be analysed in a separate dataset.
Interventions
Blended treatment (B-CBT)
B-CBT combines (blends) six individual face-to-face
CBT sessions with six to eight online CBT modules de-
livered through an Internet based treatment programme.
The face-to-face consultations will be provided by a
psychologist at the Centre for Tele-Psychiatry.
The programme is a recently developed iCBT
programme (NoDep) based on CBT for depression
which includes six mandatory modules and two optional
ones. The core components of the mandatory modules
are: psycho-education, cognitive restructuring, behav-
ioural activation, behaviour experiments, and relapse
prevention. The optional modules comprise: coping with
rumination, and restructuring of core beliefs. The deci-
sion whether to add any optional modules are taken
jointly by the patient and the psychologist based on pa-
tient needs, motivation, and possible time constraints.
See Table 1 for an overview of the intervention. All mod-
ules are delivered via multimedia elements including
video, audio, interactive exercises, calendar, and pdf
summaries. The program has a build in workflow prede-
termining the order in which the modules are presented.
All data is stored in Europe and is encrypted during
storage and transmission.
For technical support to the participants, the existing
procedures at Internetpsykiatrien are used, which con-
sists of two levels: the first is handled by the clinicians,
the second goes through an error report system to the
company providing the software (Context Consulting).
Treatment as usual (TAU)
TAU will be defined as 12 sessions of face-to-face CBT
including the same core components as the B-CBT con-
dition. Additionally, interventions on core beliefs and ru-
mination can be included according to the same criteria
as in the B-CBT condition. See Table 1 for an overview
of the intervention.
Patients in either condition is monitored weekly for
symptoms of depression including suicidal ideation and
-intent. Should any participant deteriorate or show signs
of suicidal intent, an assessment interview will be con-
ducted and the patient will be discontinued if necessary
and referred to relevant treatment.
Adherence
Participants will receive automated sms and/or e-mail re-
minders of homework assignments and questionnaires. In
case a patient is inactive for more than two days without
prior agreement with the treating psychologist, the patient
is contacted via e-mail and telephone. Additionally, a
computer is setup at the clinic, for participants to engage
with the online programme in case they are for some rea-
son not able to do so at home. This includes lack of adher-
ence even if they do not suffer technical difficulties.
Treatment fidelity
All therapists are clinical psychologists. To ensure treat-
ment fidelity (1) detailed treatment manuals, one for each
treatment condition, has been developed to guide thera-
pists through the treatment, (2) regular supervision is pro-
vided by the research coordinator to prevent drift, (3)
therapists will register the number of sessions, the fre-
quency of the sessions, the main strategies used in each
sessions and the length of each contact, and finally (4) all
sessions will be audio recorded and approximately 5% of
the sessions in each condition will be randomly selected
and evaluated by an external CBT expert (Fig. 1).
Outcome measurements
Baseline measures will be administered after consent has
been granted prior to randomisation. The participants will
be followed up three-, six-, and twelve months after base-
line measurement. In case of drop-out, a short question-
naire regarding reasons for drop-out will be administered.
All questionnaires for the participants will be administered
online. A secure web application for building and managing
online surveys (RedCap) will be used for all questionnaire
packages except the weekly monitoring for the B-CBT
group, which will be administered from within the treat-
ment programme. See Table 2 for an overview of measure-
ments and time points. Data is stored by Odense Patient
data Exploratory Network. Data is managed by a local data
manger with training and prior experience in datamange-
ment. The datamanager quality checks data continuously.
Data is collected, transferred, and stored securely electron-
ically and is approved by the Danish Data Protection
Agency (J.nr.: 14/26634 Reg. nr.: 2008-58-0035).
Primary outcome
The Patient Health Questionnaire-9 (PHQ-9) [30] will
be used as primary outcome measurement to evaluate
change in severity of depressive symptoms. It is a nine
items questionnaire which can be used to screen and
diagnose patients with depressive disorders. The nine
items are each scored on a 0–3 point scale with a total
score ranging from 0–27 with higher scores indicating
more severe depression. The PHQ-9 has been shown to
have good psychometric properties [32].
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Secondary outcomes
The Quick Inventory of Depressive Symptomatology
Self-Report (QIDS-16-SR) [33] is used in addition to the
PHQ-9 because it is a promising questionnaire for asses-
sing depressive symptoms especially in specialised men-
tal health care, whereas the PHQ-9 is developed for use
in primary care. The QIDS-16-SR is a questionnaire that
screens for depressive symptoms and assesses depression
severity. It consists of 16 items each scored on a 0–3
point scale and includes symptom domains of MDD
based on DSM-IV. The QIDS-16-SR has shown good
psychometric properties [33, 34].
The Client Satisfaction Questionnaire (CSQ-8) [35] is
used to measure the patients’ satisfaction with the
Table 1 Interventions
Session number Format of delivery Content Example of exercise
B-CBT
1 F2F Introduction and psychoeducation about depression and the
treatment
Find a helper
2 Online module Introduction to the programme, psychoeducation about
depression, and goals for the treatment
Problem- goal list
3 F2F Idiosyncratic model of the disorder Cognitive case formulation
4 Online module Psychoeducation about behaviour in depression Activity registration
5 F2F Accordance between personal values and behaviour.
Introduction to cognitive restructuring.
Simple exercise for cognitive restructuring
6 Online module Changing behaviour based on activity registration and
personal values
Activity planning
7 F2F Psychoeducation about negative automatic thoughts and
cognitive restructuring.
Cognitive restructuring exercise
8 Online module Psychoeducation about negative automatic thoughts and
cognitive restructuring.
Cognitive restructuring exercise
9 F2F Psychoeducation about behavioural experiments. Decision is
made whether to include one or both of the extra modules
Behavioural experiment
10 Online module
(A, B)
Behavioural experiments. (A: psychoeducation about core
beliefs, B: coping with rumination)
Behavioural experiment (A: challenge core
beliefs, B: test three
techniques for coping with rumination)
11 F2F Summing up, relapse prevention Continuation of preferred exercises
12 Online module Summing up, relapse prevention Personal relapse prevention plan
TAU
1 F2F Introduction and psychoeducation about depression
and the treatment
Find a helper
2 F2F Psychoeducation and goals for the treatment Problem- goallist
3 F2F Idiosyncratic model of the disorder Cognitive case formulation
4 F2F Psychoeducation about behaviour in depression Activity registration
5 F2F Accordance between personal values and behaviour.
Introduction to cognitive restructuring.
Simple exercise for cognitive restructuring
6 F2F Changing behaviour based on activity registration and
personal values
Activity planning
7 F2F Psychoeducation about negative automatic thoughts and
cognitive restructuring.
Cognitive restructuring exercise
8 F2F Psychoeducation about negative automatic thoughts and
cognitive restructuring.
Cognitive restructuring exercise
9 F2F Psychoeducation about behavioural experiments. Behavioural experiment
10 F2F Psychoeducation about core beliefs or continue working on
behavioural experiments
Challenge core beliefs or behavioural
experiment
11 F2F Psychoeducation about rumination or beginning of relapse
prevention
Test three techniques to cope with rumination
or start personal relapse prevention plan and
continuation of preferred exercise
12 F2F Summing up, relapse prevention Personal relapse prevention plan
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treatments. The questionnaire consists of eight items mea-
sured on a four point scale with total scores ranging from
8–32 and has shown good psychometric properties [36].
Clinician satisfaction with the treatment will be assessed
by the short form of the Client Satisfaction Questionnaire
including only the three core questions of the csq-8.
To measure the patients’ expectancy and judgement of
credibility of the treatments the Credibility and Expect-
ancy Questionnaire (CEQ) [37] is used. The CEQ is a
two part questionnaire measuring credibility and expect-
ancy respectively. Both factors have been shown to be
stable across different populations, with high internal
consistency within each factor [37].
To indicate whether a difference is seen in the thera-
peutic alliance the short version of the Working Alliance
Inventory (WAI-SR) is used. WAI-SR is a 12 item self-
report questionnaire with responses on a five point Likert
scale ranging from 1 (never) to 5 (always) [38, 39]. The
questionnaire covers three dimensions of working alliance:
(1) therapeutic goals, (2) tasks, and (3) bond and the sub
scales have demonstrated good internal consistencies [40].
Both the patient and the ten items therapist version of the
questionnaire will be administered. The alliance between
the patient and the programme will be assessed with the
WAI Online Therapy (TAI)(Labpsitec, 2014).
Finally, to measure the patients’ perception of the us-
ability of the software, the System Usability Scale (SUS)
[41] is used. It is a simple ten item scale giving a global
view of subjective assessments of usability of a technol-
ogy system. All items are measured on a 5-point scale
Fig. 1 Patient flow diagramme
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ranging from ‘strongly disagree’ to ‘strongly agree’. Total
SUS scores have a range from 0–100. The questionnaire
has been found to be reliable and robust [42].
Sample size and statistical analyses
The primary outcome is analysed by regressing the
three-month follow-up PHQ-9 data on the baseline
PHQ-9 score and a treatment group indicator. We will
use an ancova model for this purpose. Missing values
are handled using a full-information maximum likeli-
hood estimator. In case of dropout, we will use the last
observed values in a supplementary intention-to-treat
analysis. Missingness sensitivity will be assessed with a
best-/worst-case comparison, where missing values are
replaced with the minimum and maximum values ob-
served at follow-up.
The primary hypothesis is that the blended care inter-
vention will be no less effective than the TAU interven-
tion in reducing depression symptoms. A sample size of
130 in two balanced groups will yield a power of at least
80% to detect standardised mean differences above 0.5
on a normally distributed variable. This equivalence
interval is slightly narrower than other estimates of min-
imally clinically important differences [43].
In addition, we will compare the development of PHQ-9
in the two groups using the weekly measurements in a
mixed effects model. We will model the individual trajec-
tories as random slopes, and then let the treatment group
predict the slopes. Significant slope differences between
groups will indicate either faster or slower treatment ef-
fects in the blended care group. In case of non-normal
data, we will use an appropriate measure of transform-
ation or a generalised linear model. Variables with signifi-
cant variations between groups at baseline are introduced
as control variables.
Secondary outcomes will be analysed using t-tests or a
rank sum test. Where appropriate, differences between
baseline and follow-up scores are used as outcomes in-
stead of only comparing the follow-up score.
Discussion
The present study aims to investigate the clinical effect-
iveness of CBT delivered in a format in which face-to-
face consultations are alternated with online self-help
modules, since this could hold promise to combine ad-
vantages of Internet based guided self-help and trad-
itional CBT while preserving the clinical effectiveness
and broad applicability of traditional CBT.
It is a strength of the present study, that the treatment in
the two conditions have similar therapeutic content given
that both treatments are captured in one coherent treat-
ment manual detailing each intervention. Consequently,
Table 2 Overview of measurements
Variable Instrument Items Time (mins) Screening
Baseline
Weekly 3 months 6 months 12 months
Questions taken from participants
Demographics n/a 1 X
Current treatment n/a 2 X
Diagnostic interview M.I.N.I. n/a 15 X X
Depressive symptoms QIDS-SR16 16 3 X Item
12
X X X
PHQ-9 9 2 X X X X X
Treatment preference 1 1 X
Patient expectancy CEQ 8 2 X
Working alliance WAI-SF 12 3 X
Technology alliance TAI-SRa 12 3 X
Client satisfaction CSQ-8 8 3 X
Satisfaction with the online
programme
SUSa 20 3 X
Drop-out Number of sessions completed -
data extraction
n/a 0 X
Patients reason for drop-out.
Questionnaire
3 2 X
Questions taken from therapists
Working alliance WAI-SRT 12 3 X
Satisfaction with the online
programme
SUSb 20 3 X
aOffered to condition receiving blended treatment only, bHas to be completed once per therapist after completion of the first treatment
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the study will reveal a very direct comparison with a mini-
mum of the variance explained by differences in therapeutic
methods.
The study is limited, however, by the fact that even
though it is situated in specialised mental health care,
patients are recruited from a clinic offering self-referral.
Consequently, the results may be hard to generalise with
regards to future implementation.
The present study will contribute to the knowledge in
the field by comparing, in a direct and concise manner,
B-CBT to the well known and well investigated trad-
itional face-to-face CBT, which in many settings is con-
sidered the golden standard of psychotherapeutic
treatment of depression.
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